![Design of the PIONEER AF-PCI trial [42]. a Creatinine clearance 30-49... | Download Scientific Diagram](https://www.researchgate.net/publication/332352082/figure/fig2/AS:746553086058496@1555003534230/Design-of-the-PIONEER-AF-PCI-trial-42-a-Creatinine-clearance-30-49-mL-min-10-mg-od-b.png "Design of the PIONEER AF-PCI trial [42]. a Creatinine clearance 30-49... | Download Scientific Diagram")
Design of the PIONEER AF-PCI trial [42]. a Creatinine clearance 30-49... | Download Scientific Diagram
Cureus | Trial Sequential Analysis Comparing Bleeding and Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation and Acute Coronary Syndrome on Dual versus Triple Therapy | Article
PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study... | Download Scientific Diagram
Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter
![Design of the PIONEER AF-PCI trial [42]. a Creatinine clearance 30-49... | Download Scientific Diagram](https://www.researchgate.net/publication/332352082/figure/fig2/AS:746553086058496@1555003534230/Design-of-the-PIONEER-AF-PCI-trial-42-a-Creatinine-clearance-30-49-mL-min-10-mg-od-b_Q640.jpg "Design of the PIONEER AF-PCI trial [42]. a Creatinine clearance 30-49... | Download Scientific Diagram")
Design of the PIONEER AF-PCI trial [42]. a Creatinine clearance 30-49... | Download Scientific Diagram
Adobe AudienceManager
Xarelto® (rivaroxaban) – PIONEER
Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology
PIONEER AF-PCI: Rivaroxaban + P2Y12 Inhibitor clopidogrel ~94% or Rivaroxaban + DAPT vs. Warfarin + DAPT in Patients with Atrial
Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
Atrial Fibrillation and PCI - ppt download
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI | Challenges in Cardiology
Can the Dual vs Triple Therapy Controversy in Patients With AF Undergoing PCI Be Put to Rest? - ppt download
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? | SpringerLink
Prevention of Bleeding in Patients With Atrial Fibrillation Undergoing PCI ( PIONEER): Three May End Up Being a Crowd - Samuel A. Berkman, 2018
Studio PIONEER AF-PCI nei pazienti con fibrillazione atriale sottoposti ad angioplastica coronarica: quali risvolti clinici? - ATBV
PIONEER AF-PCI - Antithrombotics in patients with AF after PCI — NERDCAT
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation | Circulation: Cardiovascular Interventions
![PDF] Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF](https://d3i71xaburhd42.cloudfront.net/4107965fd29bd24ad0a28eea66938425b733e805/4-TableI-1.png "PDF] Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF")
PDF] Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal. - Abstract - Europe PMC
AF and PCI: How to Manage Patients on NOACs (Transcript)
PIONEER AF-PCI | Phoenix Cardiology
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy | Circulation
PIONEER AF-PCI trial overview | Thrombosis Adviser
AF and PCI in Practice. - ppt download
